Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Satraplatin (BMS182751) is an orally available antineoplastic platinum(IV) complex.Satraplatin has a favorable toxicity profile and appears to have clinical activity against a variety of malignancies.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 32,000 | |||
5 mg | 在庫あり | ¥ 75,000 | |||
10 mg | 在庫あり | ¥ 108,500 | |||
25 mg | 在庫あり | ¥ 178,500 | |||
50 mg | 在庫あり | ¥ 250,500 | |||
100 mg | 在庫あり | ¥ 335,000 |
説明 | Satraplatin (BMS182751) is an orally available antineoplastic platinum(IV) complex.Satraplatin has a favorable toxicity profile and appears to have clinical activity against a variety of malignancies. |
In vitro | KB-R cells did not show cross-resistance to satraplatin. The expression status of almost all transporters was upregulated in the KB-R cells. There was no difference in the GSH levels between the KB and KB-R cells. Flow cytometric analysis indicated that with satraplatin the G2/M phase was arrested in the KB-R cells. KB-R cells contain enriched side population cells[1]. |
細胞研究 | CDDP-resistant (KB-R) cells and parental cells (KB) pair were used. Viability was assessed using the MTT and clonogenic assay. Real-time polymerase chain reaction (PCR), glutathione (GSH) assay, and flow cytometric analysis were used for further assessment[1]. |
別名 | BMS182751, JM216, BMY45594 |
分子量 | 500.28 |
分子式 | C10H22Cl2N2O4Pt |
CAS No. | 129580-63-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33 mg/mL (65.96 mM), DMSO inactivates the activity of Satraplatin.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Satraplatin 129580-63-8 DNA Damage/DNA Repair DNA Alkylator/Crosslinker DNA Alkylation BMS 182751 BMY-45594 BMS182751 JM216 BMS-182751 BMY 45594 JM 216 Inhibitor inhibit BMY45594 JM-216 inhibitor